Back to Journals » Journal of Inflammation Research » Call For Papers

Journal of Inflammation Research

ISSN: 1178-7031


The following Article Collections/ Thematic Series are currently open for submissions:

Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes", in the Journal of Inflammation Research.

Takayasu arteritis (TAK) is a rare large vessel vasculitis (LVV). Although more common in Asia, TAK is diagnosed worldwide. The pathology of TAK is a granulomatous inflammation of the aorta and its major branches. Limited studies available from mostly Europe and North America have revealed an increased mortality risk with TAK relative to the general population. 

Much remains to be understood about TAK. The assessment of disease activity is challenging. In many instances, TAK sets in insidiously. Patients with TAK might simply be diagnosed incidentally upon the detection of asymmetry of pulses or blood pressure. On the other hand, it can also present with prominent constitutional symptoms without pulse loss at the onset or can present with severe ischemic manifestations such as stroke, myocardial infarction, or vision loss. While the pathology is an inflammatory vasculitis, in many instances, traditional inflammatory markers such as C-reactive protein (CRP) are not elevated. In such instances, 18-F fluorodeoxyglucose PET can identify active TAK even in the absence of CRP elevation. Of late, novel PET ligands such as SST2R and FAPI have been explored as denoting macrophage infiltration or fibroblast activation in the arterial wall. 

The treatment of TAK is also challenging. Despite the key pathology of vessel wall inflammation, no immunosuppressive agent has been identified to be effective in a clinical trial of TAK. There is a need to explore newer therapies or therapeutic strategies in TAK, which could include the exploration of adjunctive therapies that affect arterial wall fibrosis (which is a prominent histopathological feature of TAK) in addition to the targeting of inflammation. 

This Article Collection invites original and review articles of translational relevance in TAK, including those related to novel blood and imaging biomarkers of disease activity and arterial wall damage, novel therapeutic strategies, and biomarkers of long-term outcomes in TAK. 

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code AHYGD to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

The deadline for submitting a manuscript is 15 May 2024. If you have questions, please contact Krista Thom at [email protected].

Guest Advisor

Prof. Durga Prasanna Misra, Associate Professor, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

View all papers in this article collection

New Insights into Autoinflammatory Diseases From South America

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "New Insights into Autoinflammatory Diseases From South America", in the Journal of Inflammation Research.

The concept of autoinflammatory disease was only recognized by the medical field 20 years ago. Now, around 60 genes have been identified that lead to related inborn errors of immunity. 

Although autoinflammatory diseases have gained relevance in the medical literature data through clinical, basic, and translational research, most published research comes from high-income countries. 

Research from middle-income countries, such as those in South America, is needed to help us understand the manifestations and prevalence of these conditions in a variety of social, economic, and geographic contexts. 

This Article Collection will highlight research on autoinflammatory diseases from researchers in South America and in South American populations. We welcome original research, reviews, symposium reports, expert opinions, and commentaries. 

Topics of interest include: 

  • Genomic findings related to autoinflammatory diseases
  • Genotype/phenotype manifestations of autoinflammatory diseases
  • Pharmacological and non-pharmacological interventions in autoinflammatory diseases
  • Epidemiological data on autoinflammatory diseases
  • Environmental factors contributing to autoinflammatory diseases

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript. Standard Article Publishing Charges apply.

Please submit your manuscript on our website, quoting the promo code FGRXV to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

The deadline for submitting a manuscript is 1 October 2024. If you have questions, please contact Krista Thom at [email protected].

Guest Advisor

Leonardo Oliveira Mendonca, Professor of Clinical Immunology and Allergy, Universidade Santo Amaro, Sao Paolo, Brazil

 

View all papers in this article collection


Call For Papers

Editor-in-Chief: Professor Ning Quan

To see where the Journal of Inflammation Research is indexed online view the Journal Metrics.

What is the advantage to you of publishing in the Journal of Inflammation Research?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although the Journal of Inflammation Research receives a lot of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The Journal of Inflammation Research has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed

The Journal of Inflammation Research is indexed on PubMed Central (title abbreviation: J Inflamm Res). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Professor Ning Quan
Editor-in-Chief
Journal of Inflammation Research

Email: Editor-in-Chief